Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPT ClearPoint Neuro	$11.25 +0.7%	$12.80	$5.11 ▼ $19.22	$314.88M	0.93	245,291 shs	187,370 shs
NNOX Nano-X Imaging	$5.05 -0.2%	$5.18	$3.75 ▼ $11.00	$291.78M	1.99	1.75 million shs	614,144 shs
OBIO Orchestra BioMed	$2.99 -11.0%	$2.90	$2.37 ▼ $8.87	$114.55M	0.64	174,881 shs	667,277 shs
SMLR Semler Scientific	$31.94 +12.0%	$35.32	$21.77 ▼ $81.56	$356.18M	1.42	517,004 shs	1.56 million shs

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPT ClearPoint Neuro	0.00%	-6.87%	-12.04%	-15.92%	+114.29%
NNOX Nano-X Imaging	0.00%	-2.13%	-8.01%	-16.53%	-30.15%
OBIO Orchestra BioMed	0.00%	-5.38%	+1.36%	-33.70%	-59.81%
SMLR Semler Scientific	0.00%	+3.90%	-23.73%	-18.56%	-14.26%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CLPT ClearPoint Neuro	2.7108 of 5 stars	3.5	4.0	2.4	0.8	0.6
NNOX Nano-X Imaging	1.9878 of 5 stars	3.5	2.0	2.8	0.0	0.6
OBIO Orchestra BioMed	1.4697 of 5 stars	3.6	3.0	0.0	0.8	0.0
SMLR Semler Scientific	1.8622 of 5 stars	3.5	2.0	1.1	2.5	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLPT ClearPoint Neuro	3.00	Buy	$25.00	122.22% Upside
NNOX Nano-X Imaging	3.00	Buy	$9.50	88.12% Upside
OBIO Orchestra BioMed	3.20	Buy	$14.20	374.92% Upside
SMLR Semler Scientific	3.00	Buy	$71.00	122.29% Upside

Current Analyst Ratings Breakdown

Latest OBIO, CLPT, SMLR, and NNOX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/6/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00
5/23/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$15.00 ➝ $10.00
5/22/2025	NNOX Nano-X Imaging	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/13/2025	OBIO Orchestra BioMed	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$20.00 ➝ $20.00
5/5/2025	OBIO Orchestra BioMed	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$16.00 ➝ $12.00
4/23/2025	OBIO Orchestra BioMed	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
4/22/2025	OBIO Orchestra BioMed	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$20.00 ➝ $20.00
4/17/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$15.00 ➝ $15.00
4/4/2025	OBIO Orchestra BioMed	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$14.00 ➝ $12.00
4/3/2025	OBIO Orchestra BioMed	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
4/1/2025	CLPT ClearPoint Neuro	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$19.00 ➝ $25.00

(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLPT ClearPoint Neuro	$31.39M	10.03	N/A	N/A	$0.92 per share	12.23
NNOX Nano-X Imaging	$11.28M	25.87	N/A	N/A	$3.27 per share	1.54
OBIO Orchestra BioMed	$2.64M	43.39	N/A	N/A	$0.87 per share	3.44
SMLR Semler Scientific	$56.29M	6.33	$4.47 per share	7.14	$24.90 per share	1.28

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLPT ClearPoint Neuro	-$18.91M	-$0.76	N/A	N/A	N/A	-64.51%	-78.09%	-51.33%	8/6/2025 (Estimated)
NNOX Nano-X Imaging	-$53.52M	-$0.90	N/A	N/A	N/A	-472.19%	-30.92%	-27.73%	8/19/2025 (Estimated)
OBIO Orchestra BioMed	-$61.02M	-$1.78	N/A	N/A	N/A	-2,297.85%	-189.26%	-93.76%	N/A
SMLR Semler Scientific	$40.90M	-$2.61	N/A	∞	N/A	-60.69%	19.75%	15.47%	8/4/2025 (Estimated)

Latest OBIO, CLPT, SMLR, and NNOX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/22/2025	Q1 2025	NNOX Nano-X Imaging	-$0.23	-$0.21	+$0.02	-$0.21	$3.98 million	$3.00 million
5/13/2025	Q1 2025	CLPT ClearPoint Neuro	-$0.15	-$0.22	-$0.07	-$0.22	$8.21 million	$8.49 million
5/13/2025	Q1 2025	SMLR Semler Scientific	N/A	-$0.76	N/A	-$6.74	N/A	$8.84 million
5/12/2025	Q1 2025	OBIO Orchestra BioMed	-$0.46	-$0.49	-$0.03	-$0.49	$0.39 million	$0.87 million
3/31/2025	Q4 2024	NNOX Nano-X Imaging	-$0.15	-$0.23	-$0.08	-$0.23	$3.80 million	$3.00 million
3/31/2025	Q4 2024	OBIO Orchestra BioMed	-$0.43	-$0.43	N/A	-$0.43	$0.79 million	$0.25 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLPT ClearPoint Neuro	N/A	N/A	N/A	N/A	N/A
NNOX Nano-X Imaging	N/A	N/A	N/A	N/A	N/A
OBIO Orchestra BioMed	N/A	N/A	N/A	N/A	N/A
SMLR Semler Scientific	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLPT ClearPoint Neuro	N/A	3.53	2.57
NNOX Nano-X Imaging	N/A	5.30	5.16
OBIO Orchestra BioMed	0.85	3.35	3.34
SMLR Semler Scientific	0.59	0.52	0.51

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLPT ClearPoint Neuro	30.08%
NNOX Nano-X Imaging	21.49%
OBIO Orchestra BioMed	53.55%
SMLR Semler Scientific	49.37%

Insider Ownership

Company	Insider Ownership
CLPT ClearPoint Neuro	6.97%
NNOX Nano-X Imaging	7.74%
OBIO Orchestra BioMed	8.10%
SMLR Semler Scientific	30.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLPT ClearPoint Neuro	110	27.99 million	26.04 million	Optionable
NNOX Nano-X Imaging	190	57.78 million	53.31 million	Optionable
OBIO Orchestra BioMed	4	38.31 million	35.21 million	Not Optionable
SMLR Semler Scientific	120	11.15 million	7.78 million	Not Optionable

OBIO, CLPT, SMLR, and NNOX Headlines

Recent News About These Companies

Semler Scientific® Appoints Joe Burnett as Director of Bitcoin Strategy; Targets Owning at Least 10,000 Bitcoins by Year-End 2025 and 105,000 by Year-End 2027

June 19 at 4:45 PM | prnewswire.com

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

June 19 at 4:33 PM | globenewswire.com

Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR

June 17 at 3:15 PM | prnewswire.com

VanEck’s Sigel warns Bitcoin treasury companies as Semler Scientific approaches danger zone

June 17 at 11:58 AM | msn.com

Wolf Haldenstein Adler Freeman & Herz LLP is investigating Semler Scientific Inc.

June 17 at 8:24 AM | globenewswire.com

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

June 16, 2025 | globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLR

June 16, 2025 | accessnewswire.com

Bitcoin Accumulation Strategy Under Threat As Stock Prices Plummet, Says VanEck

June 16, 2025 | coingape.com

Bank of America Corp DE Trims Position in Semler Scientific, Inc. (NASDAQ:SMLR)

June 14, 2025 | marketbeat.com

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

June 13, 2025 | globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLR

June 13, 2025 | accessnewswire.com

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Semler Scientific, Inc. (SMLR) And Encourages Shareholders to Reach Out

June 12, 2025 | accessnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLR

June 12, 2025 | prnewswire.com

ROSEN, A TOP-RANKED FIRM, Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR

June 11, 2025 | accessnewswire.com

Tom Lee Mulls Roughed-Up Semler Scientific for 'Granny Shot' Portfolio

June 11, 2025 | coindesk.com

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Semler Scientific, Inc. (SMLR) and Encourages Shareholders to Learn More About the Investigation

June 11, 2025 | accessnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLR

June 11, 2025 | accessnewswire.com

Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR

June 10, 2025 | prnewswire.com

Traders Purchase Large Volume of Semler Scientific Call Options (NASDAQ:SMLR)

June 10, 2025 | marketbeat.com

Semler Scientific, Inc. (SMLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

June 10, 2025 | accessnewswire.com

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. ...

June 9, 2025 | gurufocus.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

OBIO, CLPT, SMLR, and NNOX Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

$11.25 +0.08 (+0.72%)

Closing price 06/18/2025 04:00 PM Eastern

Extended Trading

$11.20 -0.05 (-0.44%)

As of 06/18/2025 07:59 PM Eastern

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Nano-X Imaging NASDAQ:NNOX

$5.05 -0.01 (-0.20%)

Closing price 06/18/2025 04:00 PM Eastern

Extended Trading

$5.10 +0.05 (+0.99%)

As of 06/18/2025 07:34 PM Eastern

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Orchestra BioMed NASDAQ:OBIO

$2.99 -0.37 (-11.01%)

Closing price 06/18/2025 04:00 PM Eastern

Extended Trading

$3.17 +0.18 (+5.89%)

As of 06/18/2025 07:54 PM Eastern

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Semler Scientific NASDAQ:SMLR

$31.94 +3.41 (+11.95%)

Closing price 06/18/2025 04:00 PM Eastern

Extended Trading

$31.94 0.00 (0.00%)

As of 06/18/2025 08:00 PM Eastern

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time